Keith M. McGahan - Jun 21, 2022 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC (SPPI)

Role
Chief Legal Officer
Signature
/s/ Keith M. McGahan
Stock symbol
SPPI
Transactions as of
Jun 21, 2022
Transactions value $
$0
Form type
4
Date filed
6/23/2022, 09:13 PM
Previous filing
Mar 16, 2022
Next filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPPI Common Stock, $0.001 par value Award $0 +246K +100.47% $0.00 491K Jun 21, 2022 Direct F1
holding SPPI Common Stock, $0.001 par value 6.25K Jun 21, 2022 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPPI Stock Option (Right to Buy) Award $0 +904K $0.00 904K Jun 21, 2022 Common Stock 904K $0.63 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit grant was approved by Spectrum Pharmaceuticals, Inc.'s ("Spectrum") board of directors on January 27, 2022, subject to stockholder approval of the Amended and Restated 2018 Long-Term Incentive Plan (the "Plan") under which the restricted stock unit was granted. Spectrum's stockholders approved the Plan on June 21, 2022.
F2 The option grant was approved by Spectrum's board of directors on January 27, 2022, subject to stockholder approval of the Plan under which the option was granted. Spectrum's stockholders approved the Plan on June 21, 2022.
F3 One third of the aggregate amount of option shares shall vest on each of January 27, 2023, 2024 and 2025, respectively.